PRODUCT CODE: ET1705-89

Recombinant FTO Monoclonal Antibody (ET1705-89)

  • Recombinant

Applications

  • WB

  • IHC-P

REACTIVITY

  • Human

Western blot analysis of FTO on different lysates using anti-FTO antibody at 1/1,000 dilution.<br />
 Positive control:<br />
 Lane 1: Human fetal brain tissue <br />
 Lane 2: HepG2 <br />
 Lane 3: 293
  • Western blot analysis of FTO on different lysates using anti-FTO antibody at 1/1,000 dilution.<br />
 Positive control:<br />
 Lane 1: Human fetal brain tissue <br />
 Lane 2: HepG2 <br />
 Lane 3: 293
  • Immunohistochemical analysis of paraffin-embedded human pancreas tissue using anti-FTO antibody. Counter stained with hematoxylin.
  • Immunohistochemical analysis of paraffin-embedded human uterus tissue using anti-FTO antibody. Counter stained with hematoxylin.
  • Immunohistochemical analysis of paraffin-embedded human placenta tissue using anti-FTO antibody. Counter stained with hematoxylin.
Western blot analysis of FTO on different lysates using anti-FTO antibody at 1/1,000 dilution.
Positive control:
Lane 1: Human fetal brain tissue
Lane 2: HepG2
Lane 3: 293

Applications

  • WB

  • IHC-P

REACTIVITY

  • Human

SPECIFICATIONS

Product Type

Recombinant Rabbit monoclonal primary

Product Name

Recombinant FTO Monoclonal Antibody (ET1705-89)

Immunogen

Recombinant protein

Host

Rabbit

Positive Control

Human fetal brain tissue lysate, HepG2, 293, human placenta tissue, human pancreas tissue, human uterus tissue.

Conjugation

Unconjugated

Clonality

Monoclonal

Clone Number

JM98-30

PROPERTIES

Form

Liquid

Storage Condition

Store at +4C after thawing. Aliquot store at -20C or -80C. Avoid repeated freeze / thaw cycles.

Storage Buffer

1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.

Concentration

1 ug/ul

PURIFICATION

Protein A purified.

Isotype

IgG

APPLICATION DILUTION

  • WB

  • 1:500-1:2,000

  • IHC-P

  • 1:50-1:200

TARGET

UNIPROT #

PROTEIN NAME

FTO

SYNONYMS

AlkB homolog 9 antibody; ALKBH9 antibody; Alpha-ketoglutarate-dependent dioxygenase FTO antibody; AW743446 antibody; Fat mass and obesity-associated protein antibody; FATSO, MOUSE, HOMOLOG OF antibody; Fto antibody; FTO_HUMAN antibody; GDFD antibody; KIAA1752 antibody; mKIAA1752 antibody; Protein fatso antibody

SEQUENCE SIMILARITIES

Belongs to the fto family.

TISSUE SPECIFICITY

Ubiquitously expressed, with relatively high expression in adrenal glands and brain; especially in hypothalamus and pituitary. Highly expressed in highly expressed in acute myeloid leukemias (AML) with t(11;11)(q23;23) with KMT2A/MLL1 rearrangements, t(15;17)(q21;q21)/PML-RARA, FLT3-ITD, and/or NPM1 mutations.

SUBCELLULAR LOCATION

Nucleus.

FUNCTION

FTO, also known as Fatso or KIAA1752, is a 505 amino acid protein that has an N-terminal nuclear localization signal. Expressed in a variety of tissues, with highest levels present in brain and pancreatic tissue, Fatso exists as four alternatively spliced isoforms, one of which is associated with a predisposition to childhood and adult obesity. Due to its involvement in the development of obesity, Fatso is associated with an increased BMI and may be involved in the pathogenesis of type 2 diabetes. The gene encoding Fatso maps to human chromosome 16, which encodes over 900 genes and comprises nearly 3% of the human genome. The GAN gene is located on chromosome 16 and, with mutation, may lead to giant axonal neuropathy, a nervous system disorder characterized by increasing malfunction with growth. The rare disorder Rubinstein-Taybi syndrome is also associated with chromosome 16, as is Crohn's disease, which is a gastrointestinal inflammatory condition.